Business Context and Reporting Period
This Form 8-K is a current report filed by pSivida Corp. (not Eyepoint, Inc.) on December 21, 2016. The filing addresses corporate governance matters regarding executive compensation agreements rather than operational or financial performance results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the amendment of specific employment agreements and contains no financial statements or operational data.
Material Changes
The material change reported is the amendment of Performance-Based Restricted Stock Unit (RSU) Award Agreements for two executives:
- Nancy Lurker (President and CEO)
- Deb Jorn
On December 21, 2016, the Compensation Committee approved "Restated Agreements" to amend the original agreements dated November 2, 2016. The amendments were made to correct vesting provisions to reflect the Compensation Committee's original intent at the time of the grants.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. The document strictly details the execution of the amended RSU agreements, which are filed as Exhibits 10.1 and 10.2.
Investor Verification Checklist
- Verify the specific vesting terms in the attached Exhibits 10.1 and 10.2 to understand the corrected provisions.
- Confirm the impact of these amendments on the company's stock-based compensation expense in future financial reports.
- Note that this filing does not contain financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.